Kowal Investment Group LLC Has $575,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Kowal Investment Group LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 17.7% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,162 shares of the healthcare conglomerate’s stock after selling 250 shares during the quarter. Kowal Investment Group LLC’s holdings in UnitedHealth Group were worth $575,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Tealwood Asset Management Inc. raised its stake in shares of UnitedHealth Group by 0.4% in the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after purchasing an additional 19 shares during the last quarter. Atlas Private Wealth Advisors raised its stake in shares of UnitedHealth Group by 1.1% in the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock worth $923,000 after purchasing an additional 19 shares during the last quarter. Prentice Wealth Management LLC raised its stake in shares of UnitedHealth Group by 0.8% in the fourth quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after purchasing an additional 19 shares during the last quarter. Baker Avenue Asset Management LP grew its holdings in shares of UnitedHealth Group by 1.7% in the third quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock valued at $615,000 after acquiring an additional 20 shares in the last quarter. Finally, Granite Harbor Advisors Inc. grew its holdings in shares of UnitedHealth Group by 2.9% in the third quarter. Granite Harbor Advisors Inc. now owns 718 shares of the healthcare conglomerate’s stock valued at $362,000 after acquiring an additional 20 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

UNH has been the subject of several recent analyst reports. Barclays upped their target price on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Morgan Stanley reduced their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective for the company in a report on Wednesday, June 5th. Finally, StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday. Three analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Trading Down 2.9 %

Shares of UNH stock opened at $494.43 on Tuesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm has a market cap of $455.07 billion, a P/E ratio of 30.22, a price-to-earnings-growth ratio of 1.48 and a beta of 0.60. The business has a 50-day moving average price of $498.34 and a two-hundred day moving average price of $501.63. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.26 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were given a $2.10 dividend. The ex-dividend date was Monday, June 17th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a yield of 1.70%. UnitedHealth Group’s dividend payout ratio is 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.